304 related articles for article (PubMed ID: 29551295)
1. Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations.
Vakrakou AG; Boiu S; Ziakas PD; Xingi E; Boleti H; Manoussakis MN
J Autoimmun; 2018 Jul; 91():23-33. PubMed ID: 29551295
[TBL] [Abstract][Full Text] [Related]
2. Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren's syndrome.
Vakrakou AG; Svolaki IP; Evangelou K; Gorgoulis VG; Manoussakis MN
J Autoimmun; 2020 Mar; 108():102381. PubMed ID: 31919014
[TBL] [Abstract][Full Text] [Related]
3. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
Baldini C; Santini E; Rossi C; Donati V; Solini A
J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjögren's syndrome.
Kim SK; Choe JY; Lee GH
Clin Chim Acta; 2017 Nov; 474():147-154. PubMed ID: 28965771
[TBL] [Abstract][Full Text] [Related]
5. The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome.
Baldini C; Rossi C; Ferro F; Santini E; Seccia V; Donati V; Solini A
J Intern Med; 2013 Nov; 274(5):480-9. PubMed ID: 23906036
[TBL] [Abstract][Full Text] [Related]
6. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome.
Guggino G; Lin X; Rizzo A; Xiao F; Saieva L; Raimondo S; Di Liberto D; Candore G; Ruscitti P; Cipriani P; Giacomelli R; Dieli F; Alessandro R; Triolo G; Lu L; Ciccia F
Arthritis Rheumatol; 2018 Aug; 70(8):1265-1275. PubMed ID: 29569854
[TBL] [Abstract][Full Text] [Related]
8. Total glucosides of paeony alleviates experimental Sjögren's syndrome through inhibiting NLRP3 inflammasome activation of submandibular gland cells.
Jiang T; Guo J; Wang Y; Wu H; Chen Y; Wang S; Zhang H; Long Q; Yao G
Clin Exp Rheumatol; 2023 Dec; 41(12):2502-2510. PubMed ID: 38149512
[TBL] [Abstract][Full Text] [Related]
9. IL-27 regulates NLRP3 inflammasome activation of MDSCs in experimental Sjögren's syndrome.
Xia X; Long Q; Zha J; Jiang T; Guo J; Jiang B; Li X; Yao G
Int Immunol; 2023 Nov; 35(11):531-542. PubMed ID: 37756640
[TBL] [Abstract][Full Text] [Related]
10. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.
Vartoukian SR; Tilakaratne WM; Seoudi N; Bombardieri M; Bergmeier L; Tappuni AR; Fortune F
Clin Exp Immunol; 2014 Sep; 177(3):618-29. PubMed ID: 24827536
[TBL] [Abstract][Full Text] [Related]
12. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.
De Luca G; Lev PR; Camacho MF; Goette NP; Sackmann F; Castro Ríos MA; Moiraghi B; Cortes Guerrieri V; Bendek G; Carricondo E; Enrico A; Vallejo V; Varela A; Khoury M; Gutierrez M; Larripa IB; Marta RF; Glembotsky AC; Heller PG
Front Immunol; 2023; 14():1161832. PubMed ID: 38035089
[TBL] [Abstract][Full Text] [Related]
13. Huoxue Jiedu Recipe represses mitochondrial fission to alleviate submandibular gland inflammation in Sjögren's syndrome.
Xu J; Shen Z; Du Y; Zhang S; Xi Y; Zhang Y; Wang D; Zhu Y
Microbiol Immunol; 2023 Aug; 67(8):377-387. PubMed ID: 37340676
[TBL] [Abstract][Full Text] [Related]
14. Type I Interferon Increases Inflammasomes Associated Pyroptosis in the Salivary Glands of Patients with Primary Sjögren's Syndrome.
Hong SM; Lee J; Jang SG; Lee J; Cho ML; Kwok SK; Park SH
Immune Netw; 2020 Oct; 20(5):e39. PubMed ID: 33163247
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
Tan HY; Yong YK; Shankar EM; Paukovics G; Ellegård R; Larsson M; Kamarulzaman A; French MA; Crowe SM
J Immunol; 2016 May; 196(10):4052-63. PubMed ID: 27076678
[TBL] [Abstract][Full Text] [Related]
16. Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell.
Pitanga TN; Oliveira RR; Zanette DL; Guarda CC; Santiago RP; Santana SS; Nascimento VML; Lima JB; Carvalho GQ; Maffili VV; Carvalho MOS; Alcântara LCJ; Borges VM; Goncalves MS
Cytokine; 2016 Jul; 83():75-84. PubMed ID: 27045344
[TBL] [Abstract][Full Text] [Related]
17. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease.
Hsieh CW; Chen YM; Lin CC; Tang KT; Chen HH; Hung WT; Lai KL; Chen DY
J Rheumatol; 2017 Aug; 44(8):1142-1150. PubMed ID: 28507179
[TBL] [Abstract][Full Text] [Related]
18. Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.
Zhang H; Fu R; Guo C; Huang Y; Wang H; Wang S; Zhao J; Yang N
J Transl Med; 2016 Jun; 14(1):156. PubMed ID: 27250627
[TBL] [Abstract][Full Text] [Related]
19. USP5 negatively regulates the activation of NLRP3 inflammasomes and participates in the pathological and physiological processes of Sjogren's syndrome.
He J; Chen Y; Xu M; Wu S
Int Immunopharmacol; 2024 Jun; 135():112274. PubMed ID: 38772301
[TBL] [Abstract][Full Text] [Related]
20. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
